rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-4-5
|
pubmed:abstractText |
To evaluate the efficacy and safety of once-daily saquinavir-soft-gel-capsules/ritonavir (SQV-SGC/RTV) 1600 mg/100 mg plus dual nucleoside reverse transcriptase inhibitors (NRTIs) in HIV-infected patients with plasma viral load (pVL) <50 HIV-1 RNA copies/mL following 3 years of antiretroviral therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1464-2662
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
122-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15807718-Adult,
pubmed-meshheading:15807718-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15807718-CD4 Lymphocyte Count,
pubmed-meshheading:15807718-Drug Administration Schedule,
pubmed-meshheading:15807718-Drug Therapy, Combination,
pubmed-meshheading:15807718-Female,
pubmed-meshheading:15807718-Follow-Up Studies,
pubmed-meshheading:15807718-HIV Infections,
pubmed-meshheading:15807718-HIV Protease Inhibitors,
pubmed-meshheading:15807718-HIV-1,
pubmed-meshheading:15807718-Humans,
pubmed-meshheading:15807718-Male,
pubmed-meshheading:15807718-RNA, Viral,
pubmed-meshheading:15807718-Retrospective Studies,
pubmed-meshheading:15807718-Reverse Transcriptase Inhibitors,
pubmed-meshheading:15807718-Ritonavir,
pubmed-meshheading:15807718-Saquinavir,
pubmed-meshheading:15807718-Triglycerides,
pubmed-meshheading:15807718-Viral Load
|
pubmed:year |
2005
|
pubmed:articleTitle |
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
|
pubmed:affiliation |
The HIV Netherlands Australia Thailand Research Collaborative (HIVNAT), The Thai Red Cross AIDS Research Center, Bangkok, Thailand. Peter.Cardiello@post.harvard.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|